Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc.

CCAP
Crescent Capital BDC, Inc.US flagNASDAQ Global Market
11.00
USD
-0.12
- -
405.31MMarket Cap
Crescent Capital BDC, Inc.
CCAP
(NASDAQ Global Market)

Recent

price

11.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.01
0.5
0.38
0.25
0.84
1.76
2.98
0.75
2.57
2.25
1.28
0.71
Revenue per Share
-0.09
0.39
0.3
0.27
0.97
1.98
2.94
0.5
2.33
1.99
0.93
0.41
Basic EPS, GAAP
- -
-2.61
-2.94
-5.48
-6.76
-2.23
-5.54
0.9
2.57
1.59
2.02
1.78
Free Cash Flow per Basic Share
- -
0.18
0.27
0.45
0.82
1.54
1.68
1.79
1.8
2.03
1.83
1.78
Dividend per Share
- -
- -
0.07
-0.21
-0.25
-1.25
-0.49
-2.02
-6.22
-5.89
-6.78
-7.62
Book Value per Share
- -
- -
5.75
8.64
13.55
20.23
22.91
19.83
20.67
19.98
19.06
18.21
Tangible Book Value per Share
25
30
30
30
30
28
28
31
36
37
37
37
Basic Weighted Avg Shares
- -
15
11
8
25
49
85
23
92
84
47
26
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
12
9
8
29
55
84
16
84
74
35
15
Net Income, GAAP
- -
0.01
2.61
2.51
1.21
1.32
4.18
5.82
0.33
1.46
4.65
10.3
Effective Tax Rate (%)
-877.37
77.91
79.02
107.65
115.84
112.49
98.47
67.08
90.68
88.2
72.77
57.21
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
151
236
322
472
631
654
845
876
874
907
LT Debt
- -
- -
173
260
407
560
652
613
743
741
706
674
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
885.98
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
528
521
450

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
6
5
6
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
5.34%
-4.67%
Free Cash Flow
- -
51.65%
26.85%
Net Income, GAAP
1.36%
69.12%
-53.14%
Sales/Revenue/Turnover
656.74%
49.63%
-43.21%
Total Cash Common Dividend
- -
10.24%
-9.87%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
30
23
18
12
84
2025
7
19
10
11
47
2026
-14
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.76
0.55
0.41
- -
1.99
2025
0.11
0.41
0.19
- -
0.93
2026
-0.42
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.51
0.52
0.51
- -
2.03
2025
0.47
0.47
0.47
- -
1.83
2026
0.42
- -
- -
- -
- -
Business
Crescent Capital BDC, Inc. (CCAP) is a business development company that provides customized debt and equity financing solutions to lower middle-market companies in the United States. The company offers senior secured loans, unitranche loans, mezzanine debt, and equity co-investments; it targets companies with enterprise values between $20 million and $150 million across diversified industries including business services, consumer, and healthcare. Crescent Capital BDC, Inc. operates primarily in the U.S., with its headquarters in Los Angeles, California, and was founded in 2015 as an externally managed fund sponsored by Crescent Capital Group LP. The company maintains a portfolio of approximately 80-100 investments, focusing on control-oriented financings and non-control opportunities to generate current income and long-term capital appreciation for shareholders. In recent developments, Crescent Capital BDC, Inc. completed a $100 million equity offering in 2024 to support portfolio growth and opportunistic investments; it also announced strategic portfolio expansions into technology-enabled services and healthcare subsectors amid favorable market conditions. Additionally, the company entered into new credit facilities and participated in several sponsor-backed acquisitions during 2024-2025, enhancing its liquidity and diversification.

Company News

APIChatGPT
  • Crescent Capital: Why I Still Wouldn't Buy Even After The 19% Dividend Cut

  • Crescent Capital BDC: 19% Dividend Reset Is A Buying Opportunity

  • Crescent Capital: A Tactical 13% Yielding Case To Buy

  • New Strong Sell Stocks for June 16th

  • New Strong Sell Stocks for June 12th

  • KinderCare Applauds New York's Historic Investments in Child Care

  • Crescent Capital Group Closes Largest Fund in Firm's History with Fourth U.S. Direct Lending Fund, Raising $10.8 Billion in Investable Capital

  • The High-Yield Stocks the Smart Money Is Buying Right Now

  • Crescent Capital BDC: 13% Yield And A Discount Too Deep To Ignore

  • Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript

  • Crescent Capital BDC Q1 Earnings Call Highlights

  • Crescent Capital BDC (CCAP) Tops Q1 Earnings Estimates

  • Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends

  • Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2026 Financial Results

  • Buy These 2 SBIC & Commercial Finance Stocks Despite Industry Weakness

  • Crescent Capital BDC: Additional Downside Risks Remain (Rating Downgrade)

  • 20 BDCs And 13 Of Them Are Likely To Slash Their Dividends This Year

  • Adams Asset Advisors LLC Raises Stock Holdings in Crescent Capital BDC, Inc. $CCAP

  • After Recognising This, I've Decided To Go All In On BDCs

  • Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Recommendation of “Moderate Buy” from Brokerages